In continuation to intimation dated May 31, 2025, Metropolis Healthcare has informed that Scientific Metropolis Pathology (formerly known as Metropolis Clinical Pathology), a subsidiary of Metropolis Healthcare, has acquired the entire business of ‘Dr. Ashok Kumar Sharma’s Scientific Pathology’, a sole proprietorship firm of Dr. Ashok Kumar Sharma as a going concern, effective June 16, 2025, as per the terms agreed under the Business Transfer Agreement (‘BTA’). The other terms and conditions, including deferred consideration, will be executed in accordance with the BTA. Consequent to the above transfer, the operations of the ‘Dr. Ashok Kumar Sharma’s Scientific Pathology’ are now being carried out under Scientific Metropolis Pathology, effective June 16, 2025.
The above information is a part of company’s filings submitted to BSE.
